Legal Aspects of AI use in Health | Online webinar

Technology has developed so fast in relation to AI in recent years that the use of AI, including Chat GPT, is now becoming the norm in our lives, including healthcare.
There has been a notable surge of text-based artificial intelligence products, including but not limited to ChatGPT, GPT-4, Bard, and other prominent large language models (LLMs).
Many software companies are incorporating AI solutions into their products.
The development and use of artificial intelligence (AI) in health and biotechnology is creating opportunities and benefits for healthcare providers and consumers.
Presently, AI is being used in medical fields such as diagnostics, e-health and evidenced based medicine. A prime example has been the use of AI in the detection and management of diagnostic imaging such as thoracic imaging, mammography, and colorectal polyps.
However, a number of legal (including IP), regulatory (including software as a medical device), ethical, and social issues have arisen with the use of AI in the healthcare sector.
The issue is: can the law keep up with the pace?
Alison Choy Flannigan will discuss these issues and the impact for the health system.

Guest speaker: Alison Choy Flannigan,Partner – Hall & Wilcox

Can’t make it to the live event? Register for a ticket and watch the recorded version on demand, the link will be sent to you after the event has ended.

Date: Wednesday 5 February 2025

Time: WA 9.00am-10.00am

Registration fee inc GST
Single ACHSM Member: FREE to attend, registration essential
Single non-member $50
Group 15 and under $99
Group 15+ $199

Program: 
9.00am – Welcome, acknowledgement to country, Introduction by Adam Stormont and Sponsor address
9.05am – Presentation: Alison Choy Flannigan
9.40am – Q&A, moderated by Adam Stormont
9.55am – Closing remarks
10.00am  –  Finish

For further information on the presenter and to register, CLICK HERE.